Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia.

× No keyword cloud information.

27 in total

1. Chemotherapy-induced anemia in patients with primary lung cancer.

Authors: H Okamoto; N Saijo; T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; H Kunikane; A Karato
Journal: Ann Oncol Date: 1992-12 Impact factor: 32.976

Review 2. Progress in understanding the pathogenesis of the anemia of chronic disease.

Authors: R T Means; S B Krantz
Journal: Blood Date: 1992-10-01 Impact factor: 22.113

Review 3. Allogeneic transfusion and infection: economic and clinical implications.

Authors: N Blumberg
Journal: Semin Hematol Date: 1997-07 Impact factor: 3.851

4. Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.

Authors: L Del Mastro; M Venturini; R Lionetto; O Garrone; G Melioli; W Pasquetti; M R Sertoli; G Bertelli; G Canavese; M Costantini; R Rosso
Journal: J Clin Oncol Date: 1997-07 Impact factor: 44.544

5. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

Authors: J Glaspy; R Bukowski; D Steinberg; C Taylor; S Tchekmedyian; S Vadhan-Raj
Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544

6. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

Authors: C Leitgeb; M Pecherstorfer; E Fritz; H Ludwig
Journal: Cancer Date: 1994-05-15 Impact factor: 6.860

7. Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

Authors: J Overgaard; H S Hansen; K Jørgensen; M Hjelm Hansen
Journal: Int J Radiat Oncol Biol Phys Date: 1986-04 Impact factor: 7.038

8. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Authors: H Ludwig; E Sundal; M Pecherstorfer; C Leitgeb; T Bauernhofer; A Beinhauer; H Samonigg; A W Kappeler; E Fritz
Journal: Cancer Date: 1995-12-01 Impact factor: 6.860

9. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.

Authors: D A Fein; W R Lee; A L Hanlon; J A Ridge; C J Langer; W J Curran; L R Coia
Journal: J Clin Oncol Date: 1995-08 Impact factor: 44.544

10. Transfusion requirements, risks, and costs for patients with malignancy.

Authors: K Mohandas; L Aledort
Journal: Transfusion Date: 1995-05 Impact factor: 3.157